Just The News

Xtant Medical plans refinancing, 12-to-1 reverse stock split

4 hours ago

Xtant Medical (NYSE:XTNT) said today it launched restructuring and refinancing efforts, including a 12-to-1 reverse stock split, as it looks to reform its capital structure, meet liquidity needs, regain compliance with the NYSE and position itself for better long-term growth. The efforts include inking a restructuring and exchange agreement with ROS Acquisition Offshore, OrbiMed Royalty Opportunities […]

The post Xtant Medical plans refinancing, 12-to-1 reverse stock split appeared first on MassDevice.

7 medtech stories we missed this week: Jan. 19, 2018

5 hours ago

From Privi Medical’s FDA clearance to OrthoXel getting FDA clearance and CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Privi Medical wins FDA nod for hemorrhoid device Privi Medical has received FDA clearance for its Instalief Hemorrhoids Treatment device, according to a Jan. 18 news […]

The post 7 medtech stories we missed this week: Jan. 19, 2018 appeared first on MassDevice.

Laminate Medical launches study of VasQ hemodialysis fistula device

5 hours ago

Laminate Medical Technologies said today it launched a pivotal, FDA-cleared trial of its VasQ implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis. The Israel-based company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The device regulates […]

The post Laminate Medical launches study of VasQ hemodialysis fistula device appeared first on MassDevice.

Philips Releases Its Latest Patient Monitoring Solution in U.S.

6 hours ago

Philips is releasing its latest Patient Monitoring solution in the U.S., a product designed to help hospitals keep track of patient monitor data as they move from one clinical area to another. The offering revolves around the company’s IntelliVue X3 transport monitor and it allows clinicians to easily combine all the data gathered in the OR, ICU, […]

New clues to T cell development could boost search for HIV vaccine

6 hours ago

Scientists around the world have spent many years trying to make effective vaccines for HIV and hepatitis C, with little success. Now California scientists have discovered how some helper T cells become killer T cells, opening the door to improved vaccine design for chronic viral infections, such as hepatitis C and HIV.

New clues to T cell development could boost search for HIV vaccine

6 hours ago

Scientists around the world have spent many years trying to make effective vaccines for HIV and hepatitis C, with little success. Now California scientists have discovered how some helper T cells become killer T cells, opening the door to improved vaccine design for chronic viral infections, such as hepatitis C and HIV.

Audax begins recapitalization of Belmont Instruments

6 hours ago

Private equity player Audax Group has begun its recapitalization efforts with fluid warming infusion systems provider Belmont Instruments, according to a press release from financial advisor Mirus Capital Advisors. Billerica, Mass.-based Belmont produces rapid infusion systems designed to treat critically injured patients with material blood loss, according to Audax. “Belmont is a best-in-class provider of life-sustaining fluid warming […]

The post Audax begins recapitalization of Belmont Instruments appeared first on MassDevice.

Medizone to launch further AscepticSure testing in pursuit of FDA de novo pathway

6 hours ago

Medizone International (OTC:MZEI) said yesterday that following meetings with the FDA, it has decided to pursue de novo clearance with the agency for its AscepticSure disinfection system, and such pursuit will require further data collection on the device. The AsepticSure system is designed to be turned on from outside the room to be disinfected, enabling the machine […]

The post Medizone to launch further AscepticSure testing in pursuit of FDA de novo pathway appeared first on MassDevice.

These medtech companies raised the most VC last year

7 hours ago

Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving […]

The post These medtech companies raised the most VC last year appeared first on MassDevice.

Centinel Spine reports $132m funding round

8 hours ago

Fresh from its acquisition of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes’ Prodisc assets, Centinel Spine last week reported raising more than $132 million. In the waning days of 2017, Centinel it closed its acquisition of DePuy’s Prodisc-C, Prodisc-L, Prodisc-C Vivo, Prodisc-C Nova, Prodisc-O and Discover cervical and lumbar artificial disc systems. Although the purchase price remained undisclosed, Centinel said at […]

The post Centinel Spine reports $132m funding round appeared first on MassDevice.

International Biophysics FloPump 32 Centrifugal Disposable Heart Pump FDA Cleared

8 hours ago

International Biophysics, a firm out of Austin, Texas, won FDA clearance for its FloPump 32 centrifugal disposable heart pump. The device is designed to be powered by the Maquet ROTAFLOW console, which can be used as a stand along unit or a part of a heart-lung machine. The new pump won the CE Mark approval in […]

Pavmed prices $4.3m offering

9 hours ago

Pavmed (NSDQ:PAVM) today priced an underwritten public offering of 2,415,278 shares of its common stock at $1.80 per share. The New York City-based company said it would grant the offering’s underwriters a 45-day option to buy up to 362,292 additional shares of common stock to cover over-allotments. Pavmed expects to bring in $3.9 million in net […]

The post Pavmed prices $4.3m offering appeared first on MassDevice.

Honda wins CE Mark for Walking Assist Device

9 hours ago

Honda (NYSE:HMC) said yesterday it won CE Mark approval in the European Union for its Honda Walking Assist Device designed for walking rehabilitation. The walking assist device uses cooperative control technology, based on Honda’s cumulative study of human walking, the Japanese company said. The system is designed to help users achieve efficient walking based on […]

The post Honda wins CE Mark for Walking Assist Device appeared first on MassDevice.

Teva restructuring hits American HQ, claiming 200-plus Pennsylvania jobs

9 hours ago

Teva’s far-reaching cost cuts are hitting close to home—not just in Israel, but at its North American headquarters, too. The embattled company is laying off more than 200 workers in and around its North Wales, Pennsylvania, home base, it said in a WARN notice filed with the Pennsylvania Department of Labor and Industry.

Obalon Therapeutics prices $35m offering

10 hours ago

Obalon Therapeutics (NSDQ:OBLN) today priced an upcoming $35 million offering, looking to float 5.5 million shares at $5.50 per share. The San Diego-based medical device company won pre-market approval from the FDA for its ingestible, gas-filled balloon designed for weight loss in September 2016. The Obalon device is indicated for weight loss in adults 30 to 100 pounds overweight, with a […]

The post Obalon Therapeutics prices $35m offering appeared first on MassDevice.

FDA head Gottlieb updates on new recall info policies

10 hours ago

FDA head Dr. Scott Gottlieb yesterday announced new steps the agency is taking to improve the posting of recall notices, including earlier posting of yet-to-be classified recalls and earlier summaries of corrective actions. The notice comes a month after Dr. Gottlieb went on the record saying the agency was committed to improving its recall processes. […]

The post FDA head Gottlieb updates on new recall info policies appeared first on MassDevice.

PTC in the hot seat again over price hikes on DMD med Emflaza

10 hours ago

Shares of PTC Therapeutics jumped 15% on Jan. 8 after the company released optimistic financial projections for 2017 and 2018. But PTC is facing questions about an issue that has been dogging the company since it bought DMD drug Emflaza from Marathon last March: the drug’s rising price.

DarioHealth launches iPhone-compatible glucose meter in Australia

12 hours ago

DarioHealth (NSDQ:DRIO) said today that the Lightning-enabled version of its blood glucose monitoring system is available in Australia. The device is designed to connect with the latest Apple products, including the iPhone 7, iPhone 8 and iPhone X. The product’s launch comes just one month after it won approval from Australian authorities. Get the full story at […]

The post DarioHealth launches iPhone-compatible glucose meter in Australia appeared first on MassDevice.

Ablynx investor opens door to Novo deal at a higher price

12 hours ago

Ablynx’s largest shareholder is open to supporting a takeover by Novo Nordisk. The fund, Van Herk Investments, thinks Novo’s most recent offer was too low, but it will encourage Ablynx to enter talks if a sufficiently sweetened bid is received.

Ablynx investor opens door to Novo deal at a higher price

12 hours ago

Ablynx’s largest shareholder is open to supporting a takeover by Novo Nordisk. The fund, Van Herk Investments, thinks Novo’s most recent offer was too low, but it will encourage Ablynx to enter talks if a sufficiently sweetened bid is received.

House passes stopgap bill that would delay medical device tax; Senate Dems vow filibuster

12 hours ago

Senate Democrats vowed to filibuster a stop-gap bill aimed at keeping the federal government open past a midnight deadline today, after the U.S. House yesterday passed the budget measure which would in part put a two-year pause on the medical device tax. The 2.3% excise tax on U.S. medical device revenues was in effect for […]

The post House passes stopgap bill that would delay medical device tax; Senate Dems vow filibuster appeared first on MassDevice.

Phillips-Medisize’s increased business to benefit Molex plant in Arkansas

1 day ago

Phillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark. Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader in consumable […]

The post Phillips-Medisize’s increased business to benefit Molex plant in Arkansas appeared first on MassDevice.

Biodegradable Pressure Sensor Doesn’t Need to be Removed After Implantation

1 day ago

Researchers at the University of Connecticut have developed a biodegradable pressure sensor that can be implanted in the body and help clinicians to monitor a variety of conditions over extended periods of time. What makes this sensor different from existing ones is that it doesn’t need to be removed and will eventually dissolve in the […]

Baxter subsidiary sues B. Braun over blood filtration system

1 day ago

Baxter (NYSE:BAX) and its subsidiary Gambro filed a patent infringement lawsuit against B. Braun last week, claiming that the German medical device maker’s Omni blood purification system infringes on seven of the patents covering Baxter’s Prismaflex system. The devices are used to treat patients who have acute kidney injuries and need help filtering out the waste […]

The post Baxter subsidiary sues B. Braun over blood filtration system appeared first on MassDevice.

New Device Combines Different Ophthalmology Equipment Into Single Instrument

1 day ago

Patients receiving comprehensive eye exams have to go from one imaging device to another in order to properly assess their vision. In addition to the hassle, there are costs associated with maintaining and housing multiple pieces of equipment of which only one is usually used at any one time in a typical ophthalmology office. Now […]

Smith & Nephew touts lower readmission rates for bundled joint procedure packages

1 day ago

Smith & Nephew (NYSE:SNN) is touting a 97.3% decrease in readmission rates for joint arthroplasties using its Episode of Care Assurance Program, a bundled payment option designed to reward good patient outcomes. Working with group purchasing organization Provider PPI, the British orthopedics and wound care giant’s eCAP program combines its hip and knee implants, Pico negative-pressure wound […]

The post Smith & Nephew touts lower readmission rates for bundled joint procedure packages appeared first on MassDevice.

Cryogenic 3D Printing to Make Replica Brain and Lung Tissues

1 day ago

Printing biological tissues, a necessary precursor to creating replacement organs, is not easy, but constructing extremely soft and fragile tissues that resemble the brain and lungs is even more difficult. Researchers at Imperial College London and Kings College London are now using extremely cold temperatures in combination with 3D printing to create objects out of […]

Obalon preps $35m offering

1 day ago

Obalon Therapeutics (NSDQ:OBLN) said this week that it’s planning a share flotation worth $35 million that could swell by another $5 million if an over-allotment option is fulfilled. The San Diego-based medical device company won pre-market approval from the FDA for its ingestible, gas-filled weight-loss balloon in September 2016. The Obalon device is indicated for weight loss in adults 30 to […]

The post Obalon preps $35m offering appeared first on MassDevice.

X-Ray Pill for Colon Cancer Screening: C-Scan System Cleared in Europe

1 day ago

Traditional colonoscopies that are used to screen patients for presence of colon cancer can be physically unpleasant, much too invasive, and require diets and laxatives that leave patients feeling empty and exhausted. A new option, in the form of a pill that emits X-rays to image the colon, has just been cleared by European regulators […]

Switching off enzymes to block cell division in cancer

1 day ago

Using mass spectrometry, researchers from Sweden and the U.K. have discovered how drugs bind to the enzyme DHODH, which could lay the groundwork for more selective cancer drugs that slow or stop cell division.

Switching off enzymes to block cell division in cancer

1 day ago

Using mass spectrometry, researchers from Sweden and the U.K. have discovered how drugs bind to the enzyme DHODH, which could lay the groundwork for more selective cancer drugs that slow or stop cell division.

Bluegrass Vascular launches pivotal study for Surfacer vascular access catheter

1 day ago

Bluegrass Vascular Technologies said it enrolled the first patients in a pivotal trial of its Surfacer “inside-out” vascular access catheter. The Surfacer device is designed to provide access to the jugular vein to restore central venous access in hemodialysis patients with blocked neck veins; it won CE Mark approval in the European Union in August 2016; Bluegrass later […]

The post Bluegrass Vascular launches pivotal study for Surfacer vascular access catheter appeared first on MassDevice.

Cardiovascular Systems inks partnerships with OrbusNeich, Integer

1 day ago

Cardiovascular Systems (Nasdaq: CSII) announced today that it is expanding its product portfolio through new partnerships with OrbusNeich and Integer. The OrbusNeich partnership makes St. Paul, Minn.–based CSI the exclusive U.S. distributor of Hong Kong–based OrbusNeich‘s balloon products. The deal with Frisco, Texas–based Integer (NYSE: ITGR) involves Integer producing CSI-branded Zilient guidewires. Get the full story on our sister site Medical […]

The post Cardiovascular Systems inks partnerships with OrbusNeich, Integer appeared first on MassDevice.

How blockchains could empower patients and secure data

1 day ago

Blockchains are best known as the technology behind cryptocurrencies such as Bitcoin. But the founders of a young Atlanta-based company called Patientory think they could have another important use – securing health data and empowering patients along the way. Secure access to patient data is a major issue for the healthcare industry. Patients have a […]

The post How blockchains could empower patients and secure data appeared first on MassDevice.

Ex-baseball pro DeCinces testifies in insider trading trial

1 day ago

Former professional baseball player Doug DeCinces reportedly testified this week in the second trial of friend and neighbor James Mazzo, the former Advanced Medical Optics CEO accused of insider trading ahead of Abbott‘s (NYSE:ABT) $2.8 billion AMO acquisition in 2009. Federal prosecutors in 2014 accused Mazzo of tipping former Orioles and Angels player DeCinces about the upcoming merger (Abbott sold the business to Johnson & […]

The post Ex-baseball pro DeCinces testifies in insider trading trial appeared first on MassDevice.

FDA to expedite release of recall information

1 day ago

By: Douglas Stearn, J.D. When FDA identifies that a product it regulates violates the law, it protects the public by working with the manufacturer and distributors to facilitate the product’s recall (i.e., removal from the marketplace or product correction). Among other actions, FDA assures that the public is warned when products present the most significant […]

The post FDA to expedite release of recall information appeared first on MassDevice.

Inositec names ex-Roche, Novartis staffer as CMO

2 days ago

Inositec has named former Roche and Novartis staffer Frits van Alphen, M.D., as its CMO. Van Alphen joins Inositec as the biotech gears up to move its lead vascular calcification candidate into the clinic next year.

Inositec names ex-Roche, Novartis staffer as CMO

2 days ago

Inositec has named former Roche and Novartis staffer Frits van Alphen, M.D., as its CMO. Van Alphen joins Inositec as the biotech gears up to move its lead vascular calcification candidate into the clinic next year.

Corti Intelligent Assistant Helps Emergency Dispatchers Diagnose, Triage Callers

2 days ago

Artificial intelligence is a popular buzz term in medicine these day. While there’s a lot of simple things pretending to be smart, there are also some pretty impressive AI applications that can be very useful. Thanks to Fast Company, we learned of Corti, an AI assistant that listens to calls to emergency services (911) and […]

Robot Lengthens Disconnected Bowels to Restore a Contiguous Gut

2 days ago

A number of congenital conditions result in missing parts of the gastrointestinal tract, such as esophageal atresia, while a few others can necessitate surgical removal of a part of the bowel that then has to be reconnected. Fragile and precious newborns are perhaps the most common patients for procedures requiring bowel regeneration and reconnection. In […]

RAPAEL, a Futuristic Pegboard, Turns Boring Rehab Into a Game

2 days ago

At CES 2018 in Las Vegas, NEOFECT, a South Korean firm, was showing off its RAPAEL Smart Pegboard, a new take on a simple rehab device. Pegboards are commonly used in rehabilitation settings to practice hand dexterity, as well as to assess an individual’s state and progress. They’re particularly useful for those recovering from a stroke, […]

Hologic Brevera Biopsy System Slices and Images Breast Tissue, Now Cleared in Europe

2 days ago

Breast biopsies, which can conclusively diagnose the presence of a tumor, suffer from a number of procedural limitations. One big issue is that during the excision of every sample, the physician can’t easily confirm whether the taken tissue really does come from the targeted lesion. Hologic‘s Brevera biopsy system has now been approved in Europe to […]

Scientists reveal secrets of ‘anti-aging’ hormones

2 days ago

The hormones alpha-Klotho and beta-Klotho are often called “anti-aging” hormones because of their reputed role in regulating metabolism and longevity. Now two separate studies are unlocking the structure and function of Klotho proteins—and shedding new light on their true role in age-related disorders.

Scientists reveal secrets of ‘anti-aging’ hormones

2 days ago

The hormones alpha-Klotho and beta-Klotho are often called “anti-aging” hormones because of their reputed role in regulating metabolism and longevity. Now two separate studies are unlocking the structure and function of Klotho proteins—and shedding new light on their true role in age-related disorders.

FDA chief Gottlieb backs away from plan to publish CRLs

3 days ago

FDA Commissioner Scott Gottlieb, M.D., has backed away from an earlier commitment to publish complete response letters (CRLs). Gottlieb talked up the prospect of releasing redacted versions of the letters in his confirmation hearings but has now watered down his interest in the idea.

FDA chief Gottlieb backs away from plan to publish CRLs

3 days ago

FDA Commissioner Scott Gottlieb, M.D., has backed away from an earlier commitment to publish complete response letters (CRLs). Gottlieb talked up the prospect of releasing redacted versions of the letters in his confirmation hearings but has now watered down his interest in the idea.

In conversation with: Sarepta CEO Doug Ingram

3 days ago

After the dust had settled on another J.P. Morgan Healthcare Conference, we caught up with Doug Ingram, the relatively new chief at rare disease biotech Sarepta, and discussed how he aims to remove the term “controversial” that we bio reporters keeping slapping in front of the company’s name.

In conversation with: Sarepta CEO Doug Ingram

3 days ago

After the dust had settled on another J.P. Morgan Healthcare Conference, we caught up with Doug Ingram, the relatively new chief at rare disease biotech Sarepta, and discussed how he aims to remove the term “controversial” that we bio reporters keeping slapping in front of the company’s name.

Pherecydes raises cash to trial anti-infective phage therapies

4 days ago

Pherecydes has raised money to take bacteriophage-based anti-infectives into clinical trials. The €8.7 million ($10.6 million) series B will support studies targeting two bacterial infections and the creation of a drug manufacturing unit.

Pherecydes raises cash to trial anti-infective phage therapies

4 days ago

Pherecydes has raised money to take bacteriophage-based anti-infectives into clinical trials. The €8.7 million ($10.6 million) series B will support studies targeting two bacterial infections and the creation of a drug manufacturing unit.

Merck KGaA taps CRUK, ICR for source of cancer candidates

4 days ago

Merck KGaA has teamed up with Cancer Research UK (CRUK) to access cancer candidates. The pact sets Merck up to work with researchers at CRUK’s unit at The Institute of Cancer Research (ICR) on three preclinical oncology projects.

Merck KGaA taps CRUK, ICR for source of cancer candidates

4 days ago

Merck KGaA has teamed up with Cancer Research UK (CRUK) to access cancer candidates. The pact sets Merck up to work with researchers at CRUK’s unit at The Institute of Cancer Research (ICR) on three preclinical oncology projects.

U.K. seeks to help startups by easing access to samples, data and disease models

4 days ago

The Medicines Discovery Catapult has detailed how it plans to help biotechs in the United Kingdom address their current pain points. Officials at the government-backed unit identified efforts to make informatics tools, preclinical models, data and samples available to startups as the best uses of its resources.

U.K. seeks to help startups by easing access to samples, data and disease models

4 days ago

The Medicines Discovery Catapult has detailed how it plans to help biotechs in the United Kingdom address their current pain points. Officials at the government-backed unit identified efforts to make informatics tools, preclinical models, data and samples available to startups as the best uses of its resources.

Sanofi to refund Philippines for $28M worth of unused Dengvaxia doses

4 days ago

Facing growing demand from officials and lawmakers, Sanofi Pasteur agreed to refund the Philippine government for unused Dengvaxia doses worth about 1.4 billion Philippine pesos ($28 million). But safety questions continue to swirl after preliminary autopsy results came out from children who died after receiving Dengvaxia, though no causal link has been proven.

Hikma names ex-Fresenius scientist as global R&D chief

5 days ago

Hikma Pharmaceuticals has named Surendera Tyagi, Ph.D., as its CSO and global head of R&D. Tyagi joins Hikma with a brief to stimulate noninjectable R&D activity at a time when the company's generic drug unit is suffering.

Hikma names ex-Fresenius scientist as global R&D chief

5 days ago

Hikma Pharmaceuticals has named Surendera Tyagi, Ph.D., as its CSO and global head of R&D. Tyagi joins Hikma with a brief to stimulate noninjectable R&D activity at a time when the company's generic drug unit is suffering.

Biofrontera files for IPO to run skin cancer clinical trials

5 days ago

Biofrontera has filed for a Nasdaq IPO. The German company is seeking $22 million (€18 million) to support a clutch of clinical trials designed to expand use of Ameluz in types of skin cancer and other dermatological conditions.

Biofrontera files for IPO to run skin cancer clinical trials

5 days ago

Biofrontera has filed for a Nasdaq IPO. The German company is seeking $22 million (€18 million) to support a clutch of clinical trials designed to expand use of Ameluz in types of skin cancer and other dermatological conditions.

Fresh insights into a giant protein could improve heart health

1 week ago

Titin is the largest protein circulating throughout the human body, and it plays a key role in helping muscles function properly—especially in the heart. Now an international team of researchers has discovered a new mechanism that regulates this protein.

Fresh insights into a giant protein could improve heart health

1 week ago

Titin is the largest protein circulating throughout the human body, and it plays a key role in helping muscles function properly—especially in the heart. Now an international team of researchers has discovered a new mechanism that regulates this protein.

Payers point to Spark’s gene therapy as a model for innovative pricing plans

1 week ago

When Spark Therapeutics announced an $850,000 price for its gene therapy Luxturna last week, some critics held it up as the latest example of an expensive new treatment that could break the bank for the healthcare system. But at the J.P. Morgan Healthcare conference this week, it was clear that sentiment is rapidly changing.

Concert rethinks R&D plans after loss in Incyte patent case

1 week ago

Concert Pharmaceuticals is reassessing whether to expand CTP-543 into additional indications after its attempt to challenge an Incyte patent failed. The setback leaves Concert committed to taking the drug forward in alopecia areata but uncertain of its future beyond the indication.

Concert rethinks R&D plans after loss in Incyte patent case

1 week ago

Concert Pharmaceuticals is reassessing whether to expand CTP-543 into additional indications after its attempt to challenge an Incyte patent failed. The setback leaves Concert committed to taking the drug forward in alopecia areata but uncertain of its future beyond the indication.

3 sales tips to get off to a fast start in 2018

1 week ago

The new year always comes with lofty goals, which typically start with unused gym memberships and unproductive quarterly planning meetings. They should be useful, but many times we end up going through the motions and write out unachievable goals that

The Top 10 Medtechy Articles From 2017

2 weeks ago

Over the course of 2017, the visitors to our anonymous message boards increased as the word continued to get out about Medtechy. We have a mixed viewership of employees in the medical sales industry and investors interested in biotech and medical device.

Has Titan Medical missed their opportunity with SPORT?

1 month ago

As a medical device rep, and a once proud owner of Titan Medical stock, I am genuinely disappointed in this company because I believe they have a solid product in SPORT. The question, though, is how much longer will it be considered a solid product?

Can Instagram Be MannKind Afrezza's Best Marketing Tool?

1 month ago

Can Instagram be the pharmaceutical industry's new best friend? This post is by no means a case study, but there are certain sets of patients who actively seek out better treatment options, and patients with Diabetes are at the top of this unscientific

Medtronic and Mazor Robotics Need Each Other

3 months ago

Let's just get this out of the way: Mazor wants to grow and Medtronic needs to infuse growth into their Spine business. In other words, an acquisition does not need to happen in order for this relationship to work.

What's Next for TransEnterix after Senhance's FDA Clearance

3 months ago

In typical FDA fashion, TransEnterix received their FDA clearance letter late Friday afternoon for their Senhance surgical robot which was very welcomed by investors as the stock jumped 63% in after-hours trading. Senhance is the first new entrant into

Business Travel Tip: Watch your home TV with a streaming stick

3 months ago

Your family thinks those weekly business trips are filled with dinner at the best restaurants and stays at 5-star hotels, but we, the road warriors, know it's quite the opposite. For most of us, the most expensive meal we get is from an Outback

TransEnterix is one step closer to FDA approval for Senhance

4 months ago

With the recent stock run-up, and the year coming to a close, any TRXC investor with a pulse has seen this coming for a while now. This morning, TransEnterix announced they've submitted their AI response to the FDA, setting the stage for a

NEA Backed NeoTract Acquired by Teleflex

4 months ago

Serial entrepreneur and NEA General Partner, Josh Makower, hit another home run today when Teleflex acquired NeoTract, the company he co-founded with Ted Lamson.

MedReps 2017 Medical Sales Salary Report

7 months ago

MedReps recently released their seventh annual medical sales salary report and the information for prospective medical sales representatives continues to be invaluable.

Stryker Sues Biomet for Stealing Reps and Corporate Secrets

10 months ago

Stryker (Howmedica Osteonics Corp) takes their non-compete agreements seriously, and on Wednesday, they sued three Biomet affiliates in Texas, claiming they poached Stryker employees involved in the Foot and Ankle business.

Are you a new manager? Start with this simple book

11 months ago

So you finally got your first management job! Congrats! Don't get too used to those words, though. You won't hear them too often from this point on. Wait, you got into management for the fame and recognition? Whoops...wrong career decision if that's what

Arguments begin in appeal of ex-Stryker rep’s $750k loss

12 months ago

The oral arguments began today for the appeal of a $750,000 loss an ex-Stryker rep incurred in a lawsuit over his move to Stryker's competitor, Biomet. As previously reported, Stryker sued ex-sales reps, Chris Ridgeway and Richard Steitzer, in September

MedReps' 2017 Best Places to Work in Medical Sales

1 year ago

MedReps surveyed over 1,200 community members in order to come up with the winners and some of the biggest and well know medical sales companies came out on top. The overall winners went to: Medtronic, Johnson & Johnson and Stryker.

Three tips to whip your sales territory into shape in the new year

1 year ago

The new year always comes with lofty goals, which typically start with unused gym memberships and unproductive quarterly planning meetings. They should be useful, but many times we end up going through the motions and write out unachievable goals that

Boost sales with a simple 7 step pre-call plan

1 year ago

Pre-call plans are one of the most effective tools a sales rep can use in preparing for a sales call. However, in our experience, sales reps bypass using them unless they happen to be on a field ride with their manager.

What is medtechy and how can it benefit medical sales reps?

1 year ago

Isn't Medtechy just Cafepharma for the medical device industry? The answer is no, but we've heard that question before. We understand the similarities as both sites have anonymous messages boards for pharmaceutical and medical device companies. However, a

The Medtech[y] Minute

1 year ago

It's been a busy week on the boards and our new blog, The Ticker, so we thought it would be helpful to round up the most popular topics and articles from the week and make it easy on you.

4 Tips for Managing a New Medical Sales Territory

1 year ago

A number of sales reps think sales success happens because you can schmooze and are a likable person. There is no doubt those factors can lead to one-off successes, but long-term success in sales in due to strategy and planning.

Muddy Waters Research still coming for St. Jude Medical

1 year ago

Short seller, Muddy Waters Research, and St. Jude Medical are back at it this week in what's becoming a modern day corporate pissing match. Despite being sued by St. Jude for making "false statements, false advertising, conspiracy and manipulation of

Merck Oncology Overview

1 year ago

Earlier this week, Merck provided an update to investors on their strategy in Oncology and a review of the data presented at ESMO. The global launch strategy of KEYTRUDA across several tumor types is reviewed as well.

Mazor Robotics Reports Record System Purchase Orders

1 year ago

Mazor Robotics made a splash today when they announced the company received purchase orders for 25 systems during the third quarter, including pre-orders for the Mazor X, which is scheduled to launch later this month at the North American Spine Society

Stryker still going after ex-rep, despite bankruptcy

1 year ago

Ex-Stryker rep, Chris Ridgeway, has been in the middle of a legal battle with Stryker since September 2013 when they fired and sued him, claiming he conspired with Biomet to steal Stryker's trade secrets, pricing, and obtain a distributorship deal through

The 10 Most Expensive Prescriptions of 2016

1 year ago

Healthcare startup, GoodRx, recently published their list of the most expensive prescriptions in the U.S. The data is gathered by using actual prices from a sample claims reported by pharmacies throughout the United States.

Boston Scientific CEO on Mad Money with Jim Cramer

1 year ago

Boston Scientific CEO, Mike Mahoney, sat down with Mad Money's Jim Cramer on Wednesday evening to discuss a number of topics, including how innovation has helped Boston Scientific's stock lift over 30% in the last year.

Castlight Health Investor Presentation

1 year ago

Castlight Health presented at the Morgan Stanley Global Healthcare Conference on September 12, 2016 and we will share that presentation if it becomes available. Until then, you can listen to the audio version here: Listen to webcast.

Sun Pharma sales reps to go on strike

1 year ago

According to a report in the Business Standard, around 500 sales reps are planning a strike on September 26th after Sun Pharma allegedly failed to pay salaries and travel expenses over the last three months.

Acelity Launches PREVENA PLUS™ Incision Management System

1 year ago

San Antonio based Acelity announced the launch of their PREVENA PLUS Incision Management System, offering clinicians and hospitals versatility in applying negative pressure incision management on linear, non-linear and intersecting incisions up to 90cm in

TransEnterix, Inc. Unveils New Brand Identity for ALF-X

1 year ago

North Carolina based, TransEnterix, announced the launch of their new brand name for the ALF-X Robotic Surgical System. The surgical robotic company has changed the name of ALF-X to The Senhance Surgical Robotic System.

5 Great Books For Sales Managers

1 year ago

As sales managers, continuously adapting and testing new ideas while sticking to a process are some of the main challenges in leading a team of people with a variety of skill sets. There is no one stop shop in management skills and we've found the best

Top 5 Medtech[y] Stories From the Week: August 28 2016

1 year ago

We have assembled our most read articles from the week. Check back throughout the week to read interesting stories from the Medical Device and Pharmaceutical industries as well as stories on how to become more effective in the medical sales field.

Medtronic Q1 2017 Earnings Presentation

1 year ago

In the current quarter Medtronic revenues were off 1.5%, earnings up 13% and the reiterate FY17 guidance. We will update this post with a breakdown of Medtronic's earnings by business unit.

Touch Surgery and Ethicon Team Up for Surgeon Training App

1 year ago

Johnson & Johnson subsidiary, Ethicon, announced a strategic collaboration with Touch Surgery to help improve patient outcomes by delivering simulated surgical training of Ethicon products in a free mobile app for medical professionals.

Loading...

Email Newsletter Subscription.

Don’t you think it’s about time your (day) job got a bit easier? Us too.

Register today and we’ll add you to our mailing list.

I am a